On September 11, 2023, Sensus Healthcare, Inc. entered into a Credit Agreement with Comerica Bank (?Comerica?) pursuant to which Comerica has made a revolving credit facility (the ?Credit Facility?) available to the Company, evidenced by a Master Revolving Note, dated September 11, 2023 (the ?Note?), made by the Company in favor of Comerica. The Credit Facility provides the Company with a working capital line of credit with borrowing capacity of up to $10,000,000. Pursuant to the terms of the Note, advances made under the Credit Facility would bear interest at the Secured Overnight Financing Rate plus 2.5% per annum and would be due upon demand by Comerica.

Pursuant to a Security Agreement, dated as of September 11, 2023, made by the Company in favor of Comerica, the Credit Facility is secured by a security interest in all of the Company?s assets (the ?Collateral?). The Credit Facility may be terminated by the Company or Comerica at any time. Under the Credit Agreement, the Company must obtain Comerica?s prior written consent in order to take any of the following actions: (a) sell, lease, transfer or otherwise dispose of its assets outside the ordinary course of its business; (b) incur, create, assume or permit to exist any other indebtedness (subject to certain exceptions); (c) acquire substantially all of the properties or assets of another party; (d) make any investments or acquire any interests in any other party (subject to certain exceptions); or (e) create, incur, assume or suffer to exist any lien on any of its assets other than liens in favor of Comerica and certain other permitted liens.

The Credit Agreement contains a financial covenant requiring that the Company maintain unencumbered liquid assets having a minimum value of $3,500,000 in a Comerica account. The Credit Agreement also contains customary representations and warranties and customary events of default, upon the occurrence of which, after any applicable grace period, Comerica would have the ability to accelerate all outstanding advances, terminate the Credit Facility, and exercise remedies with respect to the Collateral.